NIMCO US, Inc. is 10% Owner at Aimmune Therapeutics, Inc. (AIMT). They have made 2 open-market trades across 2 companies since 2018, most recently 2020-05-18.
CIK 0001643723
2 open-market purchases totalling $244.4M since 2018, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.